Procalcitonin and sepsis: Hints on clinical appropriateness;Procalcitonina e sepsi: Alcuni aspetti relativi all'appropriatezza della richiesta

Biochimica Clinica

Volumn 37, Issue 1, 2013, Pages 15-22

  Pezzati, Paola ^a   Balboni, Fiamma ^b   Piazzini, Tessa ^c   Cocco, Claudio ^d   Graziani, Maria Stella ^d  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b Istituto Fiorentino di Cura e Assistenza   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

CRITICALLY ILL PATIENT; FEBRILE BONE MARROW APLASIA; HUMAN; INTENSIVE CARE UNIT; REVIEW; SEPSIS;

EID: 84875158164     PISSN: 03930564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Goldman L, Schaser AL. Goldman's Cecil Medicine. 24th ed. Philadelphia: Elsevier Saunders, 2012.
2. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 2001;29(suppl):S109-16.
3. Levy MM, Fink MP, Marshall C, et al. 2001 SCCM/ESICM/ACCP7ATS/SIS International Sepsis Definition Conference. Intensive Care Med 2003;29:530-8.
4. Carrigan S D, Scott G, Tabrizian M. Towards resolving the challenges of sepsis diagnosis. Clin Chem 2004;50:1301-14.
5. Sands KE, Bates DW, Lanken PV, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997;278:234-40.
6. Merlotti C, Luraschi P. Procalcitonina: aspetti biochimici, metabolici, clinici ed analitici. Biochim Clin 2004;28:257-67.
7. Müller B, White JC, Nylén ES, et al. Ubiquitous expression of the Calcitonin-I gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001;86:396-404.
8. Meisner M, Lohs T, Huettemann E, et al. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 2001;18:79-87.
9. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem 2003;49:1-6.
10. Linnet K, Bossuyt PMM, Moons GM, et al. Quantifying the accuracy of a diagnostic test or marker. Clin Chem 2012;58:1-10.
11. Pezzati P, Balboni F, Graziani MS. Glossario dei termini per la descrizione-valutazione dell'efficacia clinicoepidemiologica degli esami di laboratorio. Biochim Clin 2010;34:212-7.
12. Leeflang MMG, Deeks JJ, Gatsonis C, et al. Systematic reviews of diagnostic test accuracy. Ann Intern Med 2008;149:889-97.
13. Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39:206-17.
14. Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006,34:1996-2003.
15. Tang BMP, Eslick GD, Craig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007;7:210-7.
16. Sackett DL, Haynes RB. The architecture of diagnostic research. Br Med J 2002;324:539-44.
17. Ruiz-Alvarez MJ, Garcia-Valdecasa S, de Pablo R, et al. Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis. J Intensive Care Med 2009;24:63-71.
18. Jones AE, Flechtl JF, Brown MD, et al. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007;50:34-49.
19. Riedel S. Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis. Diagn Microbiol Infect Dis 2012;73:221-7.
20. Riedel S, Melendez JH, Amanda TA, et al. Procalcitonin as a marker for detection of bacteriemia and sepsis in the Emergency Department. Am J Clin Pathol 2011;135:182-9.
21. Kim MH, Lim G, Kang SY, et al. Utility of procalcitonin as an early diagnostic marker of bacteriemia in patients with acute fever. Yonsei Med J 2011;52:276-81.
22. Lai CC, Tan CK, Chen SY, et al. Diagnostic performance of procalcitonin for bacteremia in patients with bacterial infection at the emergency department. J Infect 2010;61:512-5.
23. Pierrakos P, Vincent JL. Sepsis biomarkers: a review. Critical Care 2010;14:R15.
24. Ferrante di Ruffano L, Hyde C, McCaffery KJ, et al. Assessing the value of diagnostic tests: a frame work for designing and evaluating trials. Br Med J 2012; 21;344:e686.
25. Endo S, Aikawa N, Fujishima S, et al. Usefulness of procalcitonin serum level for the discrimination of severe sepsis: a multicenter prospective study. J Infect Chemother 2008;14:244-9.
26. Giamarellos-Bourboulis EJ, Mega A, Greka P, et al. Procalcitonin: a marker to clearly differentiate systematic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 2002;28:1351-6.
27. Jensen JU, Heslet L, Jensen TH, et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006;34:2596-602.
28. Jensen JU, Hein L, Lunfgren B, et al. Procalcitonin-guided intervention against infections to increase early appropriate antibiotics and improve survival in intensive care unit: a randomized trial. Crit Care Med 2011;39:2048-58.
29. Müller F, Christ-Crain M, Bregenzer T, et al. Procalcitonin levels predict bacteremia in patients with communityacquired pneumonia. Chest 2010;138:121-9.
30. Adams ST, Levenson SH. Clinical prediction rules. Br Med J 2012;344:d831.
31. Childs JD, Cleland JA. Development and application of clinical prediction rules to improve decision making in physical therapist practice. Phys Ther 2006;86:122-31.